{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T16:59:41Z","timestamp":1772643581442,"version":"3.50.1"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,5,3]],"date-time":"2025-05-03T00:00:00Z","timestamp":1746230400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,5,3]],"date-time":"2025-05-03T00:00:00Z","timestamp":1746230400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1007\/s10067-025-07396-x","type":"journal-article","created":{"date-parts":[[2025,5,3]],"date-time":"2025-05-03T07:07:26Z","timestamp":1746256046000},"page":"2277-2285","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Association between systemic lupus erythematosus and cardiovascular health based on genetic data"],"prefix":"10.1007","volume":"44","author":[{"given":"Rui","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-Wei","family":"Cui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0381-550X","authenticated-orcid":false,"given":"Chan-Yuan","family":"Bu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiang-Yang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,5,3]]},"reference":[{"issue":"5","key":"7396_CR1","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1097\/BOR.0000000000000528","volume":"30","author":"Y Liu","year":"2018","unstructured":"Liu Y, Kaplan MJ (2018) Cardiovascular disease in systemic lupus erythematosus: an update. Curr Opin Rheumatol 30(5):441\u2013448. https:\/\/doi.org\/10.1097\/BOR.0000000000000528","journal-title":"Curr Opin Rheumatol"},{"issue":"10188","key":"7396_CR2","doi-asserted-by":"publisher","first-page":"2332","DOI":"10.1016\/S0140-6736(19)30237-5","volume":"393","author":"L Durcan","year":"2019","unstructured":"Durcan L, O\u2019Dwyer T, Petri M (2019) Management strategies and future directions for systemic lupus erythematosus in adults. Lancet 393(10188):2332\u20132343. https:\/\/doi.org\/10.1016\/S0140-6736(19)30237-5","journal-title":"Lancet"},{"issue":"10188","key":"7396_CR3","doi-asserted-by":"publisher","first-page":"2344","DOI":"10.1016\/S0140-6736(19)30546-X","volume":"393","author":"T Dorner","year":"2019","unstructured":"Dorner T, Furie R (2019) Novel paradigms in systemic lupus erythematosus. Lancet 393(10188):2344\u20132358. https:\/\/doi.org\/10.1016\/S0140-6736(19)30546-X","journal-title":"Lancet"},{"issue":"1","key":"7396_CR4","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1093\/rheumatology\/keab362","volume":"61","author":"B Moghaddam","year":"2021","unstructured":"Moghaddam B, Marozoff S, Li L, Sayre EC, Zubieta JAA (2021) All-cause and cause-specific mortality in systemic lupus erythematosus: a population-based study. Rheumatology (Oxford) 61(1):367\u2013376. https:\/\/doi.org\/10.1093\/rheumatology\/keab362","journal-title":"Rheumatology (Oxford)"},{"key":"7396_CR5","doi-asserted-by":"publisher","unstructured":"Gupta S, Kaplan MJ (2021) Bite of the wolf: innate immune responses propagate autoimmunity in lupus. J Clin Invest 131(3). https:\/\/doi.org\/10.1172\/JCI144918","DOI":"10.1172\/JCI144918"},{"issue":"3","key":"7396_CR6","doi-asserted-by":"publisher","first-page":"178","DOI":"10.2174\/1573403X15666190801122105","volume":"16","author":"S Mavrogeni","year":"2020","unstructured":"Mavrogeni S, Koutsogeorgopoulou L, Dimitroulas T, Markousis-Mavrogenis G, Boki K, Katsifis G et al (2020) Combined brain\/heart magnetic resonance imaging in systemic lupus erythematosus. Curr Cardiol Rev 16(3):178\u2013186. https:\/\/doi.org\/10.2174\/1573403X15666190801122105","journal-title":"Curr Cardiol Rev"},{"key":"7396_CR7","doi-asserted-by":"publisher","first-page":"104639","DOI":"10.1016\/j.ebiom.2023.104639","volume":"93","author":"H Olbrich","year":"2023","unstructured":"Olbrich H, Kridin K, Zirpel H, Sadik CD, Terheyden P, Thaci D et al (2023) Cutaneous lupus erythematosus is associated with an increased risk of cardiac and vascular diseases: a large-scale, propensity-matched global retrospective cohort study. EBioMedicine 93:104639. https:\/\/doi.org\/10.1016\/j.ebiom.2023.104639","journal-title":"EBioMedicine"},{"issue":"2","key":"7396_CR8","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1177\/09612033221149878","volume":"32","author":"E Song","year":"2023","unstructured":"Song E (2023) The potential causal association of systemic lupus erythematosus with congestive heart failure in the East Asian population: a two-sample Mendelian randomization study. Lupus 32(2):295\u2013298. https:\/\/doi.org\/10.1177\/09612033221149878","journal-title":"Lupus"},{"key":"7396_CR9","doi-asserted-by":"publisher","unstructured":"Ajeganova S, Hafstrom I, Frostegard J (2021) Patients with SLE have higher risk of cardiovascular events and mortality in comparison with controls with the same levels of traditional risk factors and intima-media measures, which is related to accumulated disease damage and antiphospholipid syndrome: a case-control study over 10 years. Lupus Sci Med 8(1). https:\/\/doi.org\/10.1136\/lupus-2020-000454","DOI":"10.1136\/lupus-2020-000454"},{"issue":"5","key":"7396_CR10","doi-asserted-by":"publisher","first-page":"2333","DOI":"10.1177\/0962280215597579","volume":"26","author":"S Burgess","year":"2017","unstructured":"Burgess S, Small DS, Thompson SG (2017) A review of instrumental variable estimators for Mendelian randomization. Stat Methods Med Res 26(5):2333\u20132355. https:\/\/doi.org\/10.1177\/0962280215597579","journal-title":"Stat Methods Med Res"},{"issue":"11","key":"7396_CR11","doi-asserted-by":"publisher","first-page":"100805","DOI":"10.1016\/j.xcrm.2022.100805","volume":"3","author":"J Kain","year":"2022","unstructured":"Kain J, Owen KA, Marion MC, Langefeld CD, Grammer AC, Lipsky PE (2022) Mendelian randomization and pathway analysis demonstrate shared genetic associations between lupus and coronary artery disease. Cell Rep Med 3(11):100805. https:\/\/doi.org\/10.1016\/j.xcrm.2022.100805","journal-title":"Cell Rep Med"},{"key":"7396_CR12","doi-asserted-by":"publisher","first-page":"1270401","DOI":"10.3389\/fimmu.2024.1270401","volume":"15","author":"T Tao","year":"2024","unstructured":"Tao T, Tang A, Lv L, Yuan J, Wu L, Zhao L et al (2024) Investigating the causal relationship and potential shared diagnostic genes between primary biliary cholangitis and systemic lupus erythematosus using bidirectional Mendelian randomization and transcriptomic analyses. Front Immunol 15:1270401. https:\/\/doi.org\/10.3389\/fimmu.2024.1270401","journal-title":"Front Immunol"},{"issue":"1","key":"7396_CR13","doi-asserted-by":"publisher","first-page":"22543","DOI":"10.1038\/s41598-023-49233-8","volume":"13","author":"L Zhao","year":"2023","unstructured":"Zhao L, Wu R, Wu Z, Liu X, Li J, Zhang L et al (2023) Genetically predicted 486 blood metabolites concerning risk of systemic lupus erythematosus: a Mendelian randomization study. Sci Rep 13(1):22543. https:\/\/doi.org\/10.1038\/s41598-023-49233-8","journal-title":"Sci Rep"},{"key":"7396_CR14","doi-asserted-by":"publisher","first-page":"985729","DOI":"10.3389\/fimmu.2022.985729","volume":"13","author":"M Xiang","year":"2022","unstructured":"Xiang M, Wang Y, Gao Z, Wang J, Chen Q, Sun Z et al (2022) Exploring causal correlations between inflammatory cytokines and systemic lupus erythematosus: a Mendelian randomization. Front Immunol 13:985729. https:\/\/doi.org\/10.3389\/fimmu.2022.985729","journal-title":"Front Immunol"},{"key":"7396_CR15","doi-asserted-by":"publisher","first-page":"784922","DOI":"10.3389\/fgene.2021.784922","volume":"12","author":"S Huang","year":"2021","unstructured":"Huang S, Tian F, Yang X, Fang S, Fan Y, Bao J (2021) Physical activity and systemic lupus erythematosus among European populations: a two-sample Mendelian randomization study. Front Genet 12:784922. https:\/\/doi.org\/10.3389\/fgene.2021.784922","journal-title":"Front Genet"},{"issue":"2","key":"7396_CR16","doi-asserted-by":"publisher","first-page":"116","DOI":"10.2174\/157340308784245775","volume":"4","author":"CB Zeller","year":"2008","unstructured":"Zeller CB, Appenzeller S (2008) Cardiovascular disease in systemic lupus erythematosus: the role of traditional and lupus related risk factors. Curr Cardiol Rev 4(2):116\u2013122. https:\/\/doi.org\/10.2174\/157340308784245775","journal-title":"Curr Cardiol Rev"},{"issue":"7","key":"7396_CR17","doi-asserted-by":"publisher","first-page":"e26671","DOI":"10.7759\/cureus.26671","volume":"14","author":"R Alghareeb","year":"2022","unstructured":"Alghareeb R, Hussain A, Maheshwari MV, Khalid N, Patel PD (2022) Cardiovascular complications in systemic lupus erythematosus. Cureus 14(7):e26671. https:\/\/doi.org\/10.7759\/cureus.26671","journal-title":"Cureus"},{"key":"7396_CR18","doi-asserted-by":"publisher","unstructured":"Yazdany J, Pooley N, Langham J, Nicholson L, Langham S, Embleton N et al (2020) Systemic lupus erythematosus; stroke and myocardial infarction risk: a systematic review and meta-analysis. RMD Open 6(2). https:\/\/doi.org\/10.1136\/rmdopen-2020-001247","DOI":"10.1136\/rmdopen-2020-001247"},{"issue":"4","key":"7396_CR19","doi-asserted-by":"publisher","first-page":"ytae137","DOI":"10.1093\/ehjcr\/ytae137","volume":"8","author":"MI Barradas","year":"2024","unstructured":"Barradas MI, Coutinho Dos Santos I, Duarte F, Tavares A, Martins D (2024) Systemic disease presenting as cardiac tamponade: a case report. Eur Heart J Case Rep 8(4):ytae137. https:\/\/doi.org\/10.1093\/ehjcr\/ytae137","journal-title":"Eur Heart J Case Rep"},{"issue":"2\u20134","key":"7396_CR20","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1080\/17402520600876945","volume":"13","author":"EF Borba","year":"2006","unstructured":"Borba EF, Carvalho JF, Bonfa E (2006) Mechanisms of dyslipoproteinemias in systemic lupus erythematosus. Clin Dev Immunol 13(2\u20134):203\u2013208. https:\/\/doi.org\/10.1080\/17402520600876945","journal-title":"Clin Dev Immunol"},{"key":"7396_CR21","doi-asserted-by":"publisher","first-page":"102863","DOI":"10.1016\/j.jaut.2022.102863","volume":"132","author":"Y Liu","year":"2022","unstructured":"Liu Y, Yu X, Zhang W, Zhang X, Wang M, Ji F (2022) Mechanistic insight into premature atherosclerosis and cardiovascular complications in systemic lupus erythematosus. J Autoimmun 132:102863. https:\/\/doi.org\/10.1016\/j.jaut.2022.102863","journal-title":"J Autoimmun"},{"issue":"10","key":"7396_CR22","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1191\/0961203305lu2187oa","volume":"14","author":"BL Man","year":"2005","unstructured":"Man BL, Mok CC (2005) Serositis related to systemic lupus erythematosus: prevalence and outcome. Lupus 14(10):822\u2013826. https:\/\/doi.org\/10.1191\/0961203305lu2187oa","journal-title":"Lupus"},{"issue":"4","key":"7396_CR23","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1007\/s10067-022-06469-5","volume":"42","author":"MR Hsieh","year":"2023","unstructured":"Hsieh MR, Chen YF, Chang CT, Yu KH, Fang YF (2023) Clinical and serological factors associated with lupus pericarditis: a case-control study. Clin Rheumatol 42(4):1061\u20131067. https:\/\/doi.org\/10.1007\/s10067-022-06469-5","journal-title":"Clin Rheumatol"},{"issue":"10","key":"7396_CR24","doi-asserted-by":"publisher","first-page":"e7958","DOI":"10.1002\/ccr3.7958","volume":"11","author":"H Yousefi-Koma","year":"2023","unstructured":"Yousefi-Koma H, Jalalian R, Bagheri B (2023) Acute fibrinous constrictive pericarditis and large pericardial effusion as the first manifestation of systemic lupus erythematsous disease in an adult male patient. Clin Case Rep 11(10):e7958. https:\/\/doi.org\/10.1002\/ccr3.7958","journal-title":"Clin Case Rep"},{"issue":"5","key":"7396_CR25","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1097\/01.md.0000091181.93122.55","volume":"82","author":"R Cervera","year":"2003","unstructured":"Cervera R, Khamashta MA, Font J, Sebastiani GD, Gil A, Lavilla P et al (2003) Morbidity and mortality in systemic lupus erythematosus during a 10-year period: a comparison of early and late manifestations in a cohort of 1,000 patients. Medicine (Baltimore) 82(5):299\u2013308. https:\/\/doi.org\/10.1097\/01.md.0000091181.93122.55","journal-title":"Medicine (Baltimore)"},{"issue":"11","key":"7396_CR26","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1016\/j.amjcard.2003.08.036","volume":"92","author":"SA Cauduro","year":"2003","unstructured":"Cauduro SA, Moder KG, Tsang TS, Seward JB (2003) Clinical and echocardiographic characteristics of hemodynamically significant pericardial effusions in patients with systemic lupus erythematosus. Am J Cardiol 92(11):1370\u20131372. https:\/\/doi.org\/10.1016\/j.amjcard.2003.08.036","journal-title":"Am J Cardiol"},{"issue":"9","key":"7396_CR27","doi-asserted-by":"publisher","first-page":"e010254","DOI":"10.1161\/CIRCIMAGING.119.010254","volume":"13","author":"SR Gumireddy","year":"2020","unstructured":"Gumireddy SR, Chaliki HP, Cummings KW, Freeman WK (2020) Systemic lupus erythematosus presenting as constrictive pericarditis. Circ Cardiovasc Imaging 13(9):e010254. https:\/\/doi.org\/10.1161\/CIRCIMAGING.119.010254","journal-title":"Circ Cardiovasc Imaging"},{"issue":"1","key":"7396_CR28","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s13293-019-0274-2","volume":"10","author":"JI Ramirez Sepulveda","year":"2019","unstructured":"Ramirez Sepulveda JI, Bolin K, Mofors J, Leonard D, Svenungsson E, Jonsen A et al (2019) Sex differences in clinical presentation of systemic lupus erythematosus. Biol Sex Differ 10(1):60. https:\/\/doi.org\/10.1186\/s13293-019-0274-2","journal-title":"Biol Sex Differ"},{"issue":"3","key":"7396_CR29","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.autrev.2007.11.016","volume":"7","author":"JF de Carvalho","year":"2008","unstructured":"de Carvalho JF, Bonfa E, Borba EF (2008) Systemic lupus erythematosus and \u201clupus dyslipoproteinemia.\u201d Autoimmun Rev 7(3):246\u2013250. https:\/\/doi.org\/10.1016\/j.autrev.2007.11.016","journal-title":"Autoimmun Rev"},{"issue":"5","key":"7396_CR30","doi-asserted-by":"publisher","first-page":"e39284","DOI":"10.7759\/cureus.39284","volume":"15","author":"MA Nor","year":"2023","unstructured":"Nor MA, Ogedegbe OJ, Barbarawi A, Ali AI, Sheikh IM, Yussuf FM et al (2023) Systemic lupus erythematosus and cardiovascular diseases: a systematic review. Cureus 15(5):e39284. https:\/\/doi.org\/10.7759\/cureus.39284","journal-title":"Cureus"},{"issue":"11","key":"7396_CR31","doi-asserted-by":"publisher","first-page":"3525","DOI":"10.1007\/s10067-022-06302-z","volume":"41","author":"AN Shams-Eldin","year":"2022","unstructured":"Shams-Eldin AN, Yafasova A, Faurschou M, Schou M, Sun G, Gislason GH et al (2022) Long-term risk of adverse cardiovascular outcomes associated with cutaneous lupus erythematosus: a nationwide cohort study. Clin Rheumatol 41(11):3525\u20133536. https:\/\/doi.org\/10.1007\/s10067-022-06302-z","journal-title":"Clin Rheumatol"},{"issue":"2","key":"7396_CR32","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1007\/s10067-020-05257-3","volume":"40","author":"LN Guo","year":"2021","unstructured":"Guo LN, Nambudiri VE (2021) Cutaneous lupus erythematosus and cardiovascular disease: current knowledge and insights into pathogenesis. Clin Rheumatol 40(2):491\u2013499. https:\/\/doi.org\/10.1007\/s10067-020-05257-3","journal-title":"Clin Rheumatol"},{"key":"7396_CR33","doi-asserted-by":"publisher","unstructured":"Ding Y, Fan S, Tang Y, He M, Ren M, Shi Y et al (2022) The association between blood lipids and systemic lupus erythematosus: a two-sample Mendelian randomization research. Metabolites 13(1). https:\/\/doi.org\/10.3390\/metabo13010027","DOI":"10.3390\/metabo13010027"},{"key":"7396_CR34","doi-asserted-by":"publisher","first-page":"896499","DOI":"10.3389\/fcvm.2022.896499","volume":"9","author":"S Huang","year":"2022","unstructured":"Huang S, Huang F, Mei C, Tian F, Fan Y, Bao J (2022) Systemic lupus erythematosus and the risk of cardiovascular diseases: a two-sample Mendelian randomization study. Front Cardiovasc Med 9:896499. https:\/\/doi.org\/10.3389\/fcvm.2022.896499","journal-title":"Front Cardiovasc Med"},{"key":"7396_CR35","doi-asserted-by":"publisher","first-page":"908831","DOI":"10.3389\/fimmu.2022.908831","volume":"13","author":"N Gao","year":"2022","unstructured":"Gao N, Kong M, Li X, Wei D, Zhu X, Hong Z et al (2022) Systemic lupus erythematosus and cardiovascular disease: a Mendelian randomization study. Front Immunol 13:908831. https:\/\/doi.org\/10.3389\/fimmu.2022.908831","journal-title":"Front Immunol"},{"key":"7396_CR36","doi-asserted-by":"publisher","first-page":"1042751","DOI":"10.3389\/fimmu.2022.1042751","volume":"13","author":"X Lv","year":"2022","unstructured":"Lv X, Gao X, Liu J, Deng Y, Nie Q, Fan X et al (2022) Immune-mediated inflammatory diseases and risk of venous thromboembolism: a Mendelian randomization study. Front Immunol 13:1042751. https:\/\/doi.org\/10.3389\/fimmu.2022.1042751","journal-title":"Front Immunol"},{"key":"7396_CR37","doi-asserted-by":"publisher","first-page":"1258018","DOI":"10.3389\/fphar.2023.1258018","volume":"14","author":"T Wu","year":"2023","unstructured":"Wu T, Ye L, Wang S, Huang J, Zhang J (2023) Association of lipid lowering drugs and the risk of systemic lupus erythematosus: a drug target Mendelian randomization. Front Pharmacol 14:1258018. https:\/\/doi.org\/10.3389\/fphar.2023.1258018","journal-title":"Front Pharmacol"},{"issue":"3","key":"7396_CR38","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1001\/archdermatol.2009.21","volume":"145","author":"O Durosaro","year":"2009","unstructured":"Durosaro O, Davis MD, Reed KB, Rohlinger AL (2009) Incidence of cutaneous lupus erythematosus, 1965\u20132005: a population-based study. Arch Dermatol 145(3):249\u2013253. https:\/\/doi.org\/10.1001\/archdermatol.2009.21","journal-title":"Arch Dermatol"},{"issue":"13","key":"7396_CR39","doi-asserted-by":"publisher","first-page":"2095","DOI":"10.1177\/09612033211049305","volume":"30","author":"L Gimeno-Torres","year":"2021","unstructured":"Gimeno-Torres L, Carrion-Barbera I, Duran X, Villegas E, Monfort J, Salman-Monte TC (2021) Prevalence and risk factors for serositis in patients with systemic lupus erythematosus: a case-control study. Lupus 30(13):2095\u20132101. https:\/\/doi.org\/10.1177\/09612033211049305","journal-title":"Lupus"},{"issue":"3","key":"7396_CR40","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1136\/ard-2022-223035","volume":"82","author":"J Tian","year":"2023","unstructured":"Tian J, Zhang D, Yao X, Huang Y, Lu Q (2023) Global epidemiology of systemic lupus erythematosus: a comprehensive systematic analysis and modelling study. Ann Rheum Dis 82(3):351\u2013356. https:\/\/doi.org\/10.1136\/ard-2022-223035","journal-title":"Ann Rheum Dis"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-025-07396-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-025-07396-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-025-07396-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T13:21:14Z","timestamp":1749129674000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-025-07396-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,3]]},"references-count":40,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["7396"],"URL":"https:\/\/doi.org\/10.1007\/s10067-025-07396-x","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,3]]},"assertion":[{"value":"18 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 May 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent of participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"None.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}